Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Open-market sale CHIEF BUSINESS OFFICER sold 1,385 shares at $6.73 ($9,321)
  2. 4 Open-market sale SEE REMARKS sold 1,617 shares at $6.74 ($10,899)
  3. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 4,539 shares at $6.73 ($30,547)
  4. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,227 shares at $6.74 ($8,270)
  5. 4 Open-market sale SEE REMARKS sold 1,405 shares at $6.74 ($9,470)
  6. 4 Grant or award Director acquired 4,792 shares (grant or award)
  7. 4 Grant or award Director acquired 4,884 shares (grant or award)
  8. 4 Grant or award Director acquired 8,915 shares (grant or award)
  9. 4 Grant or award Director acquired 9,088 shares (grant or award)
  10. 4 Grant or award CHIEF BUSINESS OFFICER acquired 36,847 shares (grant or award)
  11. 4 Grant or award Director acquired 6,956 shares (grant or award)
  12. 4 Grant or award SEE REMARKS acquired 37,559 shares (grant or award)
  13. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 36,144 shares (grant or award)
  14. 4 Grant or award SEE REMARKS acquired 49,356 shares (grant or award)
  15. 4 Grant or award SEE REMARKS acquired 48,698 shares (grant or award)
  16. 4 Grant or award Director acquired 4,884 shares (grant or award)
  17. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 158,873 shares (grant or award)
  18. 4 Grant or award Director acquired 2,502 shares (grant or award)
  19. 4 Grant or award Director acquired 1,600 shares (grant or award)
  20. 4 Grant or award CHIEF BUSINESS OFFICER acquired 9,625 shares (grant or award)

Page 4 of 15 · 288 filings